Skip to main content
TipRanks
Go Ultimate75% OFF

Hanx Biopharmaceuticals (Wuhan) Co. Ltd. Class H (3378) Balance Sheet

Hanx Biopharmaceuticals (Wuhan) Co. Ltd. Class H Balance Sheet

Hanx Biopharmaceuticals (Wuhan) Co. Ltd. Class H's total assets for Q2 2019 were ¥22.68B, an increase of 6.71% from the previous quarter. HK:3378 total liabilities were ¥10.66B for the fiscal quarter, a 14.82% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 21Dec 20Dec 19Dec 18Dec 17
¥ 26.47B¥ 24.00B¥ 22.93B¥ 21.25B¥ 20.91B
¥ 15.81B¥ 11.40B¥ 10.56B¥ 9.28B¥ 9.07B
¥ 5.89B¥ 5.83B¥ 5.65B¥ 5.36B¥ 5.22B

Currency in CNY

Hanx Biopharmaceuticals (Wuhan) Co. Ltd. Class H Liabilities to Assets

010B20B30B40 %48 %56 %64 %LiabilitiesLiabilities to Assets20172018201920202021AssetsLiabilitiesLiabilities to Assets